RecruitingNCT06601829
Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital
Studying Autosomal recessive polycystic kidney disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sohag University
- Intervention
- abdominal ultrasound(other)
- Enrollment
- 30 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Sohag university Hospital, Sohag, Egypt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06601829 on ClinicalTrials.govOther trials for Autosomal recessive polycystic kidney disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07201025Imaging Assessments of ARPKD Kidney Disease ProgressionThe Cleveland Clinic
- RECRUITINGPHASE3NCT04782258A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)Otsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGNCT01401998ARPKD Database StudyChildren's Hospital of Philadelphia
See all trials for Autosomal recessive polycystic kidney disease →